YUHSpace

BROWSE

Export
18 76

Cited 0 times in

Cited 0 times in

FURVENT: Phase 3 trial of firmonertinib vs chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 20 insertion mutations (FURMO-004)

DC Field Value Language
dc.contributor.author조병철-
dc.date.accessioned2025-06-27T03:11:45Z-
dc.date.available2025-06-27T03:11:45Z-
dc.date.issued2025-01-
dc.identifier.issn0169-5002-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/206169-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherElsevier Scientific Publishers-
dc.relation.isPartOfLUNG CANCER-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleFURVENT: Phase 3 trial of firmonertinib vs chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 20 insertion mutations (FURMO-004)-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorAlexander Spira-
dc.contributor.googleauthorByoung Chul Cho-
dc.contributor.googleauthorEnriqueta Felip-
dc.contributor.googleauthorEdward B Garon-
dc.contributor.googleauthorKoichi Goto-
dc.contributor.googleauthorMelissa Johnson-
dc.contributor.googleauthorNatasha Leighl-
dc.contributor.googleauthorAntonio Passaro-
dc.contributor.googleauthorDavid Planchard-
dc.contributor.googleauthorSanjay Popat-
dc.contributor.googleauthorJames Chih-Hsin Yang-
dc.contributor.googleauthorXiaoqian Lu-
dc.contributor.googleauthorYong Jiang-
dc.contributor.googleauthorJack Huang-
dc.contributor.googleauthorMorgan Lam-
dc.contributor.googleauthorMarcin Kowanetz-
dc.contributor.googleauthorShirley Wang-
dc.contributor.googleauthorJohn Le-
dc.contributor.googleauthorJerry Y Hsu-
dc.contributor.googleauthorCai-Cun Zhou-
dc.identifier.doi10.1016/j.lungcan.2024.108066-
dc.contributor.localIdA03822-
dc.relation.journalcodeJ02174-
dc.identifier.eissn1872-8332-
dc.identifier.pmid39764938-
dc.subject.keywordAdvanced-
dc.subject.keywordEGFR-
dc.subject.keywordEGFR-TKI-
dc.subject.keywordEx20ins-
dc.subject.keywordExon 20 insertions-
dc.subject.keywordFirmonertinib-
dc.subject.keywordFurmonertinib-
dc.subject.keywordMetastatic-
dc.contributor.alternativeNameCho, Byoung Chul-
dc.contributor.affiliatedAuthor조병철-
dc.citation.volume199-
dc.citation.startPage108066-
dc.identifier.bibliographicCitationLUNG CANCER, Vol.199 : 108066, 2025-01-
dc.identifier.rimsid89149-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Show simple item record Find it @ YMLIB

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links